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1  | INTRODUC TION
Congenital heart defects (CHD) affect approximately 8–10 per 
1,000 child births (van der Linde et al., 2011). Besides their cardiac 
issues, it has been shown that children with CHD also suffer from a 
variety of other systemic health problems (Radford, Thong, Beard, 
& Ferrante, 1990). Several studies have shown the increased sus-
ceptibility of these children to different infections, for example 
respiratory tract infections, endocarditis and brain abscesses 
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Abstract
Objectives: (a) To compare levels of pro- and anti-inflammatory mediators in saliva 
and gingival crevicular fluid (GCF) in children with and without congenital heart de-
fects (CHD cases and controls) and to test whether a systemic component exists in 
CHD cases by controlling for gingivitis and plaque scores. (b) To correlate the levels 
of pro- and anti-inflammatory mediators in GCF and saliva with plaque bacterial com-
position among CHD cases and controls.
Materials and Methods: Whole un-stimulated saliva and GCF samples were collected 
(60 CHD cases, 60 controls [Sudan]) and were analysed for levels of prostaglandin E2 
(PGE2), interleukin-1β (IL-1β), tumour necrosis factor-α (TNF-α), interleukin-1ra (IL-
1ra) and interleukin-10 (IL-10) levels. These levels were correlated with the previously 
reported levels of four red complex bacteria.
Results: Significantly elevated levels of PGE2 and IL-1β in GCF and IL-1β and TNF-α 
in saliva were detected among CHD cases compared with controls. General linear 
model (GLM) analyses revealed that PGE2 and IL-1β levels remained significantly 
higher in GCF and saliva samples, respectively, among CHD cases after controlling 
for gingivitis and plaque score, whereas TNF-α and IL-10 levels were significantly 
lower in their GCF samples. Additionally, IL-1β level was significantly positively cor-
related to the counts of the four red complex species in their GCF.
Conclusion: In addition to higher levels of some pro-inflammatory mediators in saliva 
and GCF corresponding to more gingivitis in CHD cases, also a systemic inflamma-
tory component exists and is reflected in these two oral fluids.
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(Canpolat et al., 2015; Ishiwada et al., 2005; Shu-yuan, 1989). 
These infections are often severe, prolonged, recurrent and chal-
lenging to treat (Radford & Thong, 1988). An earlier study sug-
gested that this susceptibility is not only a consequence of their 
impaired cardiac function but rather due to some degree of im-
mune deficiencies that is commonly associated with CHD (Radford 
& Thong, 1988). Furthermore, the concurrent occurrence of CHD 
with several immunodeficiency syndromes led to further studies 
to explore the immunological profiles among children with CHD 
(Khalil, Trehan, Tiwari, Malik, & Arora, 1994; Radford, Lachman, 
& Thong, 1986; Radford et al., 1990). Serum sample analyses 
have been conducted to compare the level of several immuno-
logical components (immunoglobulin, complement factors, B 
cells, T helper and T suppressor cells) between children with CHD 
and their healthy counterparts and have revealed significant dif-
ferences (Khalil et al., 1994; Radford et al., 1990; Dorothy Jane 
Radford et al., 1986). Those studies concluded that children with 
CHD have a higher predisposition to infections and this could be 
partially explained by possible underlying immunological distur-
bances (Khalil et al., 1994; Radford et al., 1990).
With regard to the oral health of the children with CHD, stud-
ies have also shown that they are more prone to prevalent and 
long-lasting gingival inflammation compared to their healthy coun-
terparts (Nosrati et al., 2013; Steelman et al., 2000) and that they 
harbour higher counts of several bacterial species that are known 
to be involved in initiation and progression of caries and gingival 
inflammation (Steelman et al., 2000; Steelman, Rosen, Nelson, 
& Kenamond, 2003). We recently demonstrated that a group of 
Sudanese children with CHD were found to harbour altered bac-
terial profiles which were correlated with higher cariogenicity and 
perio-pathogenicity (Ali et al., 2017). However, the mechanism 
behind the severe and prolonged gingivitis particularly among 
children with CHD is still unclear. Bacteria have long been known 
as powerful immune-stimulatory elements (including several viru-
lence factors and lipopolysaccharide antigens [LPS]), which initi-
ate local inflammatory and immune responses (Birkedal-Hansen, 
1993). Mediators are released mainly include interleukin-1 (IL-1), 
interleukin-6 (IL-6), tumour necrosis factor α (TNF-α) and the ara-
chidonic acid derivative prostaglandin E2 (PGE2) (Birkedal-Hansen, 
1993; Faizuddin, Bharathi, & Rohini, 2003; Ulker, Tulunoglu, 
Ozmeric, Can, & Demirtas, 2008). Following the inflammatory 
process, different molecules such as interleukin-10 (IL-10), in-
terleukin-4 (IL-4), interleukin-11 (IL-11) are produced to enhance 
resolution and return tissues to normal homeostasis (Hasturk, 
Kantarci, & Van Dyke, 2012; Kinane & Attström, 2005; Opal & 
DePalo, 2000; Van Dyke & Serhan, 2003). The disturbance of the 
balance between pro-inflammatory and anti-inflammatory pro-
cesses has also been associated with the delayed resolution of in-
flammation and tissue destruction (Hasturk et al., 2012; Kinane & 
Attström, 2005; Van Dyke & Serhan, 2003).
These immune products are present in varying amounts within 
the oral fluids, including gingival crevicular fluid (GCF) and saliva 
(Bostanci et al., 2013; Chiappin, Antonelli, Gatti, Palo, & Elio, 2007; 
Delima & Van Dyke, 2003; Grant et al., 2010; Taylor & Preshaw, 
2016). Both saliva and GCF have been investigated for the mea-
surement of inflammatory processes in the periodontal tissues and 
were considered superior to serum analysis (Jaedicke, Preshaw, & 
Taylor, 2016; Taylor & Preshaw, 2016). In addition, saliva has long 
been proposed as a diagnostic tool with proven effectiveness for 
investigations of several other systemic conditions (Khaitan, Kabiraj, 
Bhattacharya, Ginjupally, & Jha, 2015; Lima et al., 2010; Matczuk, 
Zendzian-Piotrowska, Maciejczyk, & Kurek, 2017; Pappa, Kousvelari, 
& Vastardis, 2018).
On the other hand, studies have shown that the development 
of atherosclerosis begins earlier during childhood in children with 
CHD and they are at higher risk of developing vascular diseases 
and their complications upon reaching adulthood (Bresolin et al., 
2013; Giannakoulas et al., 2009; Nosrati et al., 2013; Pemberton 
et al., 2010). This increased risk among children with CHD has also 
been linked to the enhanced levels of systemic inflammatory me-
diators following prolonged gingival inflammation, together with 
other risk factors, which might contribute to future development 
of acquired heart diseases and atherosclerosis (Dyke & Winkelhoff, 
2013). A study from Brazil demonstrated that improved oral hy-
giene and periodontal treatment provided to children with CHD 
resulted in marked reduction of blood lipid parameters which are 
known as risk factors for future atherosclerosis (Bresolin et al., 
2013).
Most of the previously reported findings have focused on sys-
temically derived inflammatory mediators but no study has been re-
ported comparing the levels of a panel of inflammatory mediators in 
GCF and saliva of children with CHD. Given the possible underlying 
immune insufficiency found in some of the children with CHD, we 
hypothesize that the more severe gingival inflammation observed 
will be reflected as increased inflammatory mediators and reduced 
amounts of anti-inflammatory molecules in their saliva and GCF 
compared to healthy children. Therefore, the aims of the study were 
as follows:
1. To measure the levels of selected pro- and anti-inflammatory 
mediators in saliva and GCF samples in children with CHD 
(CHD cases) compared with levels in their healthy counterparts 
(controls) and to test if a systemic component exists in CHD 
cases by controlling for gingivitis and plaque scores.
2. To study the expression of pro- and anti-inflammatory mediators 
in GCF and saliva samples and to correlate them with plaque bac-
terial composition among CHD cases and controls.
2  | MATERIAL S AND METHODS
2.1 | Study subjects
A total number of 120 children from Khartoum city were enrolled in 
this study: 60 with CHD (CHD cases) and 60 controls (Ahmed Gasim 
cardiac Centre for CHD cases and schools and kindergartens for the 
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controls). Details regarding the setting, sampling and study design 
were previously reported (Ali et al., 2016). Children with confirmed 
diagnosis with a CHD in the age group 3–12 years were included, 
but critically ill children and those using medications other than for 
CHDs were excluded (Ali et al., 2016). Data collection was done in 
2011 and in 2014 (Ali et al., 2016). In the current study, analyses 
were performed in children examined in 2014 when saliva and GCF 
samples were included (Ali et al., 2016).
Congenital heart defects cases and controls were matched for 
age, gender and use of antibiotics (frequency or group matching). 
Children underwent oral clinical examination, with plaque and gin-
givitis measured using simplified forms of the Gingival Index (GI) 
and the Plaque index (PI) (Ainamo & Bay, 1975) including measure-
ments from six sextant teeth (55/16, 51/11, 65/26, 75/36, 71/31 and 
85/46). Dichotomous scoring for gingivitis was used, where visual 
inflammation and a tendency to spontaneous bleeding was scored 
as 1, while the absence of these signs was scored as 0. The same 
scoring system was used for measuring plaque, where the presence 
of visible plaque on at least one surface was given the score of 1 and 
the absence of plaque 0.
2.2 | Saliva sample collections
Whole saliva samples (un-stimulated) were collected from all chil-
dren (60 CHD cases, 60 controls). They were instructed to allow 
saliva to collect in their mouths before gently emptying into a 
sterile 2 ml tube. The un-stimulated whole saliva (UWS) samples 
were processed by centrifuging for 10 min at 4°C at 10,000 g in 
a micro-centrifuge (Beckman Coulter Microfuge 22 R Centrifuge). 
Each supernatant was dispensed into two tubes and stored in 
liquid nitrogen for further analysis. Saliva protein contents were 
measured using NanoDrop UV-Vis spectrophotometer at 260 and 
280 nm.
2.3 | Collection of GCF samples
Perio-paper (PERIOPAPER® Gingival Fluid Collection Strips; 
Oraflow Inc) was used for collection of GCF from the mesio-
buccal site of the four posterior teeth (55/16, 65/26, 75/36, and 
85/46). Prior to the GCF collection, the area was isolated with 
cotton rolls, and thereafter, a perio-paper was placed in the sub-
gingival sulcus for 15 s. The perio-papers were stored in an empty 
tube at −80°C.
2.3.1 | Protein measurement in GCF
Gingival crevicular fluid perio-papers were embedded in 230 ml Tris 
buffer (12 mM [pH 7.6]). Then, GCF samples were centrifuged at 4°C 
at 10,000 × g in a micro-centrifuge for 5 min and the supernatants 
were stored at −80°C. BCA™ Protein Assay Kit (PIERCE Thermo 
Fisher Scientific Inc.) was used for the protein measurement follow-
ing manufacturer's instructions.
2.3.2 | Analyses of PGE2
Following sample preparation, GCF and saliva samples were analysed 
using ELISA kits (NEOGEN CORPORATION) for the detection of pros-
taglandin E2 mediator following the instructions from the manufac-
turer. Plates precoated with monoclonal antibodies against PGE2 were 
used. Samples were diluted in the assay buffer of the ELISA kit with a 
dilution factor of 1:10. The plate was read at 450 nm, and concentra-
tions were measured by FLUO star OPTIMA in ng/ml for the samples.
2.3.3 | Multiplex fluorescent bead-based 
immunoassay
Bead-based multiplex immunoassay was performed using a custom-
made assay for the detection of four cytokines from the Bio-plex Pro 
Human Cytokine-plex assay Group 1 (Bio-Rad Laboratories). Two 
pro-inflammatory cytokines were selected for detection (IL-1β and 
TNF-α) as well as two anti-inflammatory cytokines (IL-1ra and IL-10) 
following the manufacturer's instructions. The plates were then ana-
lysed using the Luminex platform (Luminex), also known as xMAP, 
for the processing of the Bio-Plex® 200 systems. Concentrations 
measured are presented as pg/ml for saliva and GCF samples.
2.4 | Plaque bacterial composition (members of the 
red and orange complexes)
The amount of the bacterial members of the red complex (Tannerella 
forsythia (T. forsythia) , Porphyromonas gingivalis (P. gingivalis), 
Eubacterium nodatum (E. nodatum) and Terponema denticola (T. den-
ticola) has previously been reported in pooled plaque samples taken 
from the four posterior teeth of each child in the two groups and 
described in detail (Ali et al., 2017). Briefly, the collected plaque sam-
ples were kept in sterile tubes and stored at −80°C. DNA extraction 
and purification were done using Master-Pure TM DNA Purification 
kits (EPICENTRE Biotechnologies) and the DNA–DNA hybridization 
(Checkerboard) technique. We followed the procedures described 
by Socransky et al. where DNA extracted from known numbers of 
bacteria was used for the creation of standard curves used for esti-
mation of counts (Socransky et al., 2004). The mean counts of red 
bacterial species in the plaque samples from 60 CHD cases and 60 
controls were previously published (Ali et al., 2017).
2.5 | Ethical approvals
For the CHD cases, ethical approvals were obtained from Ahmed 
Gasim Hospital, Federal Ministry of Health Sudan, Research Ethical 
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Committee at the University of Science and Technology, and ethi-
cal approval was also obtained from the Regional Committee for 
Medical Research Ethics Western Norway (No. 2265) Biobank 
(No.2355). For the controls, ethical approvals were obtained from 
the State Ministry of Education (Khartoum), the State Ministry of 
Primary and Pre-school Education in the three localities of the 
capital Khartoum. Confidentiality was ensured, and a translated 
consent form was filled out and signed by the participants’ guard-
ians upon agreement to participate (both cases and controls).
2.6 | Statistical analysis
Data were entered and analysed using Statistical Package for the 
Social Science (SPSS) version 22. Data are presented as medians of 
the readings (continuous variables) and the Mann–Whitney test was 
used for the comparisons. General linear models were used for con-
trolling the potential effect of the differences in levels of gingivitis 
and plaque among the two groups on the analysed inflammatory 
mediators. A p value of .05 was used to evaluate the statistical sig-
nificance. Spearman's rho test was used to determine the correlation 
between the level of each of the investigated mediators and the level 
of each of the red complex bacterial species (T. forsythia, P. gingivalis, 
E. nodatum and T. denticola).
3  | RESULTS
There were no significant differences in distribution of age 
(CHD = 7.09 ± 2.68 years, controls = 6.93 ± 2.56 p = .750), gender 
(CHD males = 50%, controls males = 48.3% p = .853) or antibiotic 
use (CHD cases = 54.9%, controls = 45.1%) between CHD cases and 
controls (p = .307). The mean number of sites with gingivitis for CHD 
cases was significantly higher compared to controls (GI = 4.3 ± 1.9 
vs. 1.9 ± 1.9) as well as the mean number of sites with plaque 
(PI = 5.1 ± 1.5 vs. 3.9 ± 2.1, with (p = .001) and (p = .002), respectively.
Saliva samples were analysed for PGE2, and the results showed 
that it was detected among 85% of CHD cases compared to 65% of 
controls (p < .05). PGE2 level was considerably higher among CHD 
cases compared with controls in both saliva and GCF, but reached 
the statistical significance only in the latter (Table 1).
Additional analyses using both saliva and GCF samples were car-
ried out to determine the levels of the pro-inflammatory cytokines 
IL-1β and TNF-α, as well as the anti-inflammatory cytokines IL-10 and 
IL-1ra. IL-1β was found in significantly enhanced levels in both saliva 
and GCF samples of the CHD cases compared to controls (Table 1). 
While on the other hand, TNF-α level in the GCF samples was signifi-
cantly lower among the CHD cases but in contrast was significantly 
higher in saliva samples compared to controls (Table 1). Comparisons 
also revealed that IL-10 was found in significantly higher levels in 
saliva samples, while IL-1ra was significantly higher in both fluids 
among CHD cases compared with controls (Table 2).
General linear regression models (GLMs) were used to control 
for the effect of the level of gingivitis and plaque upon all mediators 
analysed. In the saliva samples, GLM regression revealed that IL-1β 
was the only inflammatory mediator that persisted in significantly 
higher level among CHD cases compared with controls (Table 3). 
For the GCF samples, GLM regression revealed that the pro-inflam-
matory mediator PGE2 remained significantly higher among the 
CHD cases while TNF-α level remained significantly lower among 
TA B L E  1   Levels of the lipid mediator PGE2 and the pro-inflammatory cytokines in GCF and saliva samples
 
GCF Saliva
CHD Cases (n = 57) Controls (n = 57) p value CHD cases (n = 54) Controls (n = 52) p value
PGE2
Median 5.98 ng/15 s 5.09 ng/15 s .009** 0.56 ng/ml 0.28 ng/ml .152
(Min–Max) 2.95–9.72 3.15–13.50  0.00–1.97 0.00–2.25  
 CHD Cases (n = 58) Controls (n = 58)  CHD Cases (n = 34) Controls (n = 44)  
IL-1β
Median 413.58 pg/15 s 316.45 pg/15 s .033* 29.91 pg/ml 9.05 pg/ml .001**
(Min–Max) 69.84–1,674.03 42.09–1,458.63  0.00–174.32 0.00–131.12  
 CHD Cases (n = 58) Controls (n = 58)  CHD Cases (N = 34) Controls (N = 44)  
TNF-α
Median 10.89 pg/15 s 15.69 pg/15 s .001** 22.70 pg/ml 8.72 pg/ml .019*
(Min-Max) 0.39–36.96 1.32–39.27  0.00–83.76 0.00–69.90  
Note: Comparisons between CHD cases and controls for levels of prostaglandin E2, interleukin-1β (IL-1β) and tumour necrosis factor-α (TNF-α) in 
gingival crevicular fluid (GCF) and saliva samples using Mann–Whitney test.
Abbreviation: n, number of children.
*p < .05 
**p < .01. 
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the CHD cases. The anti-inflammatory IL-10 turned out to be sig-
nificantly lower in the GCF among CHD cases compared with the 
controls (Table 4). Further correlation analyses revealed that IL-1β 
detected in GCF was the only pro-inflammatory mediator that 
had a significant positive correlation with the levels of the all four 
bacterial species of the red complex (Table 5), while none of the 
pro- and anti-inflammatory mediators in saliva showed significant 
correlations with any of the red complex bacterial species (data not 
shown).
4  | DISCUSSION
The current study is the first to investigate the levels of pro- and 
anti-inflammatory mediators in both saliva and GCF samples 
from CHD cases and to correlate them to plaque bacterial status. 
Findings revealed distinct differences in the levels of both pro and 
anti-inflammatory mediators between CHD cases and controls in 
saliva and GCF samples. The pro-inflammatory response was in 
general more dominant in the CHD cases in both fluids. Since the 
CHD cases had higher scores of gingivitis and plaque, we sought 
to investigate whether the above-mentioned differences were due 
to different levels of gingivitis and plaque between the two groups 
of children. GLM were used to control for the differences and re-
vealed that IL-1β was the only factor that maintained significant 
higher levels in saliva samples among the CHD cases, and demon-
strate a systemic contribution to the level of this cytokine in CHD 
cases.
In GCF, PGE2 maintained a significant higher level and IL-10 at 
a lower level in CHD cases even after controlling for gingivitis and 
plaque score, the findings indicate that an inflammatory component 
is reflected in GCF. The pro-inflammatory cytokine IL-1β was signifi-
cantly higher in CHD cases in GCF, but after controlling for GI and 
PI the difference was no longer significant and indicates that the cy-
tokine is mainly produced locally in gingiva due to higher GI in CHD 
cases compared to controls.
The systemic component of saliva is known to be more dominant 
than in the GCF. By comparing the two fluids, we hoped to identify 
mediators most likely to be altered due to a systemic effect and to 
a local oral effect in CHD cases. GCF best reflects local periodontal 
responses since the fluid is derived from the gingival extracellular 
fluid (Greabu et al., 2009). Fortunately, this quantification has re-
cently been made more efficient by advances in the technologies 
for detecting small concentrations in low fluid volumes which had 
been the main challenges in analysing oral GCF (Matczuk et al., 2017; 
Pappa et al., 2018). Our findings demonstrate that parallel analyses 
TA B L E  2   Levels of anti-inflammatory cytokines in GCF and saliva samples
 
GCF Saliva
CHD Cases (n = 58) Controls (n = 57) p value CHD Cases (n = 54) Controls (n = 55) p value
IL-10
Median 7.62 pg/15 s 8.64 pg/15 s .110 2.54 pg/ml 1.84 pg/ml .013*
(Min–Max) 1.56–24.63 1.56–31.68  0.78–22.22 0.33–94.60  
 CHD Cases (n = 34) Controls (n = 44)  
CHD Cases 
(N = 34) Controls (N = 44)  
IL-1ra
Median 145,617.42 pg/15 s 119,072.13 pg/15 s .022* 11,289.18 pg/ml 6,378.03 pg/ml .015*
(Min–Max) 34,735.26–490,660.08 12,462.06–449,637.51  0.00–64,087.88 0.00–323,615.36  
Note: GCF, gingival crevicular fluid; interleukin-10 (IL-10) and interleukin-1ra (IL-1ra), Mann–Whitney test was used for comparisons. n = number of 
children.
*p < .05; Level of significance is .05. 
TA B L E  3   Pro- and anti-inflammatory mediator levels in saliva of CHD cases and controls
Inflammatory mediator
CHD cases (n = 34)
Mean ± SD
Controls (n = 44)
Mean ± SD p Value
PGE2 (ng/ml) 0.63 ± 0.46 0.51 ± 0.64 .603
IL-1β (pg)/ml 52.56 ± 54.35 19.98 ± 32.11 .013*
TNF-α (pg/ml) 25.00 ± 22.04 15.74 ± 19.21 .220
IL-10 (pg/ml) 3.67 ± 3.76 4.64 ± 14.35 .805
IL-1ra (pg/ml) 15,611.28 ± 15,837.91 15,228.89 ± 49,496.96 .973
Note: Comparison of the levels of pro- and anti-inflammatory mediators in saliva samples between CHDs cases and controls using the general linear 
models while controlling for gingivitis and plaque scores. N = number of children.
*p < .05. 
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of both fluids give important additional information as also observed 
in previous studies (Matczuk et al., 2017; Pappa et al., 2018).
In the present study, PGE2 was measured in saliva and GCF 
samples because it is one of the immune products known to indi-
cate a local chronic ongoing inflammatory process and is a robust 
marker for measuring tissue inflammatory condition (Kalinski, 2012). 
PGE2 is a member of the prostanoid family and a product of ara-
chidonic acid derivatives produced by the sequential actions of the 
cyclo-oxygenase-2 (PTGS2/COX2) enzymes (Yao et al., 2009). It is 
found abundantly at inflammation sites and mediates tissue dam-
age by suppressing acute inflammatory mediators while promoting 
immune responses associated with chronic inflammation (Kalinski, 
2012; Yao et al., 2009). The present findings show that significantly 
more CHD cases compared to controls had detectable levels of 
PGE2 in saliva and higher mean levels of PGE2 in both saliva and 
GCF samples than controls. This increased PGE2 can be explained by 





Mean ± SD p Value
PGE2 (ng/15 s) 6.15 ± 1.62 5.256 ± 1.45 .013*
IL-1β (pg/15 s) 487.25 ± 422.79 455.965 ± 315.38 .616
TNF-α (pg/15 s) 11.37 ± 7.79 17.311 ± 8.27 .002**
IL-10 (pg/15 s) 7.87 ± 4.64 10.661 ± 5.95 .023*
IL-1ra (pg/15 s) 164,556.61 ± 86,835.80 132,331.88 ± 85,491.16 .117
Note: Comparisons of levels of pro- and anti-inflammatory mediators in GCF samples between CHDs cases and controls using the general linear 
models while controlling for gingival index and plaque index scores. CHD cases are 34 and controls are 44 children.
*p < .05. 
**p  < .01 
TA B L E  5   Pro- and anti-inflammatory mediators in GCF in relation to the bacteria levels of the red complex
Inflammatory mediator
CHD cases Controls
Bacterial species Correlation coefficient p Value Correlation coefficient p Value
PGE2 T. forsythia .235 .055 .060 .772
P. gingivalis −.002 .985 −.075 .714
E. nodatum .131 .289 .004 .984
T. denticola .170 .168 .006 .976
IL-1β T. forsythia .582 .0001** −.058 .722
P. gingivalis .383 .018* .179 .270
E. nodatum .524 .001** .027 .869
T. denticola .437 .006** .105 .518
TNF-α T. forsythia −.128 .431 −.113 .518
P. gingivalis −.292 .071 −.147 .398
E. nodatum −.198 .226 −.167 .338
T. denticola −.281 .083 −.235 .174
IL-10 T. forsythia −.138 .397 −.010 .950
P. gingivalis −.102 .536 .056 .740
E. nodatum −.151 .360 .093 .577
T. denticola −.115 .486 −.104 .535
IL-1ra T. forsythia .180 .280 .220 .179
P. gingivalis .070 .683 .013 .939
E. nodatum .093 .584 .136 .410
T. denticola .051 .764 −.007 .965
Note: Each mediator was correlated to each bacterial specious of the red complex bacteria. Spearman's rho test was used for the correlation analyses. 
CHD cases (n = 57) and controls (n = 58). GCF, gingival crevicular fluid.
*p < .05. 
**p < .01. 
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the higher red complex bacterial counts, and the latter is previously 
published (Ali et al., 2017). We suggested in the previous study that 
these higher counts of red complex bacteria may be attributed to 
changes in the oral microenvironment which favour the growth of 
these bacteria and/or to poor oral hygiene, and/or to the intake of 
more cariogenic nutrition in children with CHD.
IL-1β is a key pro-inflammatory cytokine that plays an import-
ant role in the cellular response to microbial infection (Schenk et al., 
2014). It is involved in a variety of cellular activities including immune 
activation, cytokine release and differentiation of monocytes to 
dendritic cells (Schenk et al., 2014). Locally, IL-1β plays a fundamen-
tal role in periodontal tissue destruction following exposure to var-
ious pathogens such as the red complex bacteria (Sanchez, Miozza, 
Delgado, & Busch, 2013). This relationship was also supported by 
correlation analyses, where the level of IL-1β was significantly pos-
itively correlated to the levels of the four members of the red com-
plex, in particular; T. forsythia and E. nodatum. This relationship was 
also demonstrated by the fact that red complex bacterial species 
(P. gingivalis, T. forsythia and E. nodatum) were all shown to be linked 
to gingival and periodontal diseases because of their potential vir-
ulence factors, and their presence in > 70% of cases of periodontal 
disease cases (How, Song, & Chan, 2016). Porphyromonas gingivalis 
being the mostly studied species since it's known to possess several 
virulence factors, such as cysteine proteinases (gingipain), lipopoly-
saccharide, capsule and fimbriae. T. forsythia, in addition, is thought 
to exacerbate periodontal disease via symbiosis with the highly 
pathogenic P. gingivalis and T. denticola (Falcao & Bullón, 2019).
Moreover, the significant lower TNF-α level in the GCF samples 
of CHD cases might also be associated with the suppressive actions 
of PGE2 in gingiva that has been reported to reduce the production 
of several pro-inflammatory cytokines, including TNF-α, which pro-
mote a shift towards chronic inflammation (Kalinski, 2012).
Periodontal tissue destruction has also been shown to be pro-
moted by the delayed clearance of leucocytes at the site of in-
flammation (Deo & Bhongade, 2010). This clearance is mediated 
by several anti-inflammatory mediators, including IL-10, IL-1ra and 
several other interleukins (Deo & Bhongade, 2010). IL-1ra acts by 
antagonizing the action and production of IL-1 for the purpose of 
dampening the pro-inflammatory IL-1 activity (Gabay, Lamacchia, & 
Palmer, 2010). It was demonstrated, however, that IL-1ra concentra-
tion needs to exceed the IL-1 concentration by 100- or 1,000-folds 
in order to reach an inhibitory effect (Slotwinska, 2013). In the cur-
rent study, significant differences in saliva and GCF levels of IL-1ra 
between CHD cases and controls were seen, but when controlling 
for GI and PI in GLM, no such differences between the groups were 
found. These findings support an oral contribution of this cytokine 
in the two fluids, and not a systemic one.
With respect to methodology, saliva and GCF samples are both 
considered superior to serum analysis with respect to reflection of 
oral inflammatory processes (Greabu et al., 2009). The GCF volume 
measurement was not applicable in the present study due to the 
fieldwork settings, and cytokine levels are therefore presented as 
amounts/15 s, which is a limitation of this study. The use of ELISA 
to measure the inflammatory mediators is considered the gold stan-
dard, as was used in conjunction with the multiplex immunoassay, 
which is reported to have good sensitivity and specificity (Tighe, 
Ryder, Todd, & Fairclough, 2015). The use of dichotomous scoring 
of gingivitis in the current study did not reveal the degree of sever-
ity of gingival inflammation. However, we chose to the dichotomous 
GI due to the expected low cooperation of young children and to 
avoid long-lasting dental examinations. In addition, the consulting 
cardiologist advised us to not to provoke any unnecessary bleeding, 
and therefore, the least invasive index for the scoring of gingivitis 
was chosen.
We therefore conclude from the present findings that the levels 
of IL-1β and PGE2 in both saliva and GCF samples were significantly 
elevated among CHD cases compared with controls, respectively. 
In addition, the levels IL-1β in GCF were associated with higher lev-
els of red complex bacterial counts. We also observed a systemic 
inflammatory component in both GCF and saliva since PGE2 and 
IL-1β remained significantly elevated, respectively, in CHD cases 
after controlling for gingivitis and plaque scores. Our study con-
firms therefore that CHD cases have a systemic inflammation that 
is reflected in oral fluids and can possibly make them more vul-
nerable to develop more severe periodontal diseases later in their 
lifespan. It is particularly important to prevent development of 
periodontal diseases in CHD cases by focusing on improved oral 
hygiene.
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